Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sonja Bendig

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Leukemia & Lymphoma|August 12, 2021
Whole genome sequencing demonstrates substantial pathophysiological differences of <i>MYC</i> rearrangements in patients with plasma cell myeloma and B-cell lymphomaSonja Bendig, Wencke Walter, Manja Meggendorfer, et al.
Leukemia & Lymphoma|November 5, 2021
Diagnostic challenge of identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving <i>BCL11B</i> in acute leukemias of ambiguous lineage: an analysis of eight patientsSonja Bendig, Anna Stengel, Wencke Walter, et al.
Hemasphere|September 6, 2023
Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?Miriam Kelm, Franziska Darzentas, Nikos Darzentas, et al.
British Journal of Haematology|October 25, 2024
Next-generation sequencing and high DNA input identify previously missed measurable residual disease in peripheral blood of B-cell precursor acute lymphoblastic leukaemiaSonja Bendig, Sandra Bufe, Michaela Kotrova, et al.
Frontiers in Immunology|February 23, 2026
Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from <i>in vitro</i> assaysMiriam Kelm, Nourhan Nasr, Sonja Bendig, et al.
Hemasphere|April 20, 2026
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALLNadine Wolgast, Thomas Beder, Mayukh Mondal, et al.
Annals of Hematology|February 11, 2026
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trialLars Fransecky, Walter Fiedler, Christoph Röllig, et al.
Blood Cancer Journal|January 6, 2026
Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemiaSophie Steinhäuser, Thomas Beder, Emely Hübner, et al.
Blood|March 25, 2025
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturationMichaela Kotrova, Constantin Proske, Nikos Darzentas, et al.
Hemasphere|August 30, 2023
The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across AgeThomas Beder, Björn-Thore Hansen, Alina M Hartmann, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Leukemia & Lymphoma|August 12, 2021
Whole genome sequencing demonstrates substantial pathophysiological differences of <i>MYC</i> rearrangements in patients with plasma cell myeloma and B-cell lymphomaSonja Bendig, Wencke Walter, Manja Meggendorfer, et al.
Leukemia & Lymphoma|November 5, 2021
Diagnostic challenge of identifying cases with recurrent t(8;14)(q24.21;q32.2) Involving <i>BCL11B</i> in acute leukemias of ambiguous lineage: an analysis of eight patientsSonja Bendig, Anna Stengel, Wencke Walter, et al.
Hemasphere|September 6, 2023
Dominant T-cell Receptor Delta Rearrangements in B-cell Precursor Acute Lymphoblastic Leukemia: Leukemic Markers or Physiological γδ T Repertoire?Miriam Kelm, Franziska Darzentas, Nikos Darzentas, et al.
British Journal of Haematology|October 25, 2024
Next-generation sequencing and high DNA input identify previously missed measurable residual disease in peripheral blood of B-cell precursor acute lymphoblastic leukaemiaSonja Bendig, Sandra Bufe, Michaela Kotrova, et al.
Frontiers in Immunology|February 23, 2026
Blinatumomab-driven T-cell activation in αβ and γδ T-cell subsets: insights from <i>in vitro</i> assaysMiriam Kelm, Nourhan Nasr, Sonja Bendig, et al.
Hemasphere|April 20, 2026
IntegrateALL: An end-to-end RNA-seq analysis pipeline for multilevel data extraction and interpretable subtype classification in B-precursor ALLNadine Wolgast, Thomas Beder, Mayukh Mondal, et al.
Annals of Hematology|February 11, 2026
Venetoclax and Blinatumomab for adult patients with relapsed/refractory or MRD positive Ph-negative B-cell precursor ALL: phase I part of the GMALL-BLIVEN trialLars Fransecky, Walter Fiedler, Christoph Röllig, et al.
Blood Cancer Journal|January 6, 2026
Isocitrate dehydrogenase 1 mutations drive downregulation of IL1R1 and dysregulated inflammatory response in acute myeloid leukemiaSophie Steinhäuser, Thomas Beder, Emely Hübner, et al.
Blood|March 25, 2025
NGS-based IG/TR rearrangement profiling in acute lymphoblastic leukemia: age dependence of immunogenetic maturationMichaela Kotrova, Constantin Proske, Nikos Darzentas, et al.
Hemasphere|August 30, 2023
The Gene Expression Classifier ALLCatchR Identifies B-cell Precursor ALL Subtypes and Underlying Developmental Trajectories Across AgeThomas Beder, Björn-Thore Hansen, Alina M Hartmann, et al.
Pageof 2